3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Locally Advanced Head and Neck Carcinoma
2
Carcinoma, Non-Small-Cell Lung
2
Breast Neoplasms
2
Stomach Neoplasms
1
Neoplasms
1
Multiple Endocrine Neoplasia Type 1
1
Malnutrition
1
Malabsorption Syndromes
1
Hyperphagia
1
Hematopoietic and Lymphatic System Neoplasm
1
Hematologic Neoplasms
1
Fanconi Anemia
1
Esophageal Neoplasms
1
Digestive System Diseases
1
Colorectal Neoplasms
1
Carcinoma, Squamous Cell
1
Carcinoma, Hepatocellular
1
Cachexia
1
Body Weight
1
Anus Neoplasms
1
Interventions
Gemcitabine
32
Cisplatin
31
durvalumab
15
pembrolizumab
14
Fluorouracil
13
Oxaliplatin
12
Leucovorin
12
Capecitabine
10
Bevacizumab
8
lenvatinib
7
Nivolumab
7
zanidatamab
4
Trastuzumab
4
S 1 (combination)
4
Paclitaxel
4
Liquid Biopsy
4
Irinotecan
4
Carboplatin
4
Albumin-Bound Paclitaxel
4
tremelimumab
3
tislelizumab
3
irinotecan sucrosofate
3
Injections
3
Folfox protocol
3
130-nm albumin-bound paclitaxel
3
toripalimab
2
pertuzumab
2
niraparib
2
ivosidenib
2
envafolimab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Biliary Tract Neoplasms
×
Dietary Supplements
×
1 year
×
Clear all
No trials found.